LITHIUM AND DRUG-INTERACTIONS

被引：22

作者：

AMDISEN, A ^{[1
]}

机构：

[1] AARHUS UNIV, CLIN CHEM LAB, DK-8240 RISSKOV, DENMARK

来源：

DRUGS | 1982年 / 24卷 / 02期

关键词：

D O I：

10.2165/00003495-198224020-00003

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：133 / 139

页数：7

共 57 条

[1] ACUTE BRAIN SYNDROME ASSOCIATED WITH LITHIUM THERAPY [J].

AGULNIK, PL ;

MOORE, P ;

DIMASCIO, A .

AMERICAN JOURNAL OF PSYCHIATRY, 1972, 129 (05) :621-&

[2] SERUM LEVEL MONITORING AND CLINICAL PHARMACOKINETICS OF LITHIUM [J].

AMDISEN, A .

CLINICAL PHARMACOKINETICS, 1977, 2 (02) :73-92

[3]

AMDISEN A, 1982, PHARMACOPSYCHIATRY

[4]

AYD FJ, 1980, HALOPERIDOL UPDATE 1, P83

[5] ADVERSE REACTIONS IN TREATMENT WITH LITHIUM-CARBONATE AND HALOPERIDOL [J].

BAASTRUP, PC ;

HOLLNAGEL, P ;

SORENSEN, R ;

SCHOU, M .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1976, 236 (23) :2645-2646

[6] LITHIUM AND IODINE COMBINATION THERAPY FOR THYROTOXICOSIS [J].

BOEHM, TM ;

BURMAN, KD ;

BARNES, S ;

WARTOFSKY, L .

ACTA ENDOCRINOLOGICA, 1980, 94 (02) :174-183

[7] USE OF PANCURONIUM-BROMIDE IN PATIENTS RECEIVING LITHIUM-CARBONATE [J].

BORDEN, H ;

CLARKE, MT ;

KATZ, H .

CANADIAN ANAESTHETISTS SOCIETY JOURNAL, 1974, 21 (01) :79-82

[8]

BOTTERMANN P, 1979, ACTA ENDOCRINOL-COP, V91, P37

[9]

BOUDOURESQUES G, 1980, NOUV PRESSE MED, V9, P2580

[10]

BRACCINI T, 1981, Encephale, V7, P29

← 1 2 3 4 5 6 →